Cargando…
Stem Cell Therapy for Bronchopulmonary Dysplasia: Bench to Bedside Translation
Bronchopulmonary dysplasia (BPD), a chronic lung disease affecting very premature infants, is a major cause of mortality and long-term morbidities despite of current progress in neonatal intensive care medicine. Though there has not been any effective treatment or preventive strategy for BPD, recent...
Autores principales: | Ahn, So Yoon, Chang, Yun Sil, Park, Won Soon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414632/ https://www.ncbi.nlm.nih.gov/pubmed/25931779 http://dx.doi.org/10.3346/jkms.2015.30.5.509 |
Ejemplares similares
-
Stem cells for bronchopulmonary dysplasia in preterm infants: A randomized controlled phase II trial
por: Ahn, So Yoon, et al.
Publicado: (2021) -
Trends in Survival and Incidence of Bronchopulmonary Dysplasia in Extremely Preterm Infants at 23–26 Weeks Gestation
por: Kim, Jin Kyu, et al.
Publicado: (2016) -
An Update on Translating Stem Cell Therapy for Stroke from Bench to Bedside
por: Dailey, Travis, et al.
Publicado: (2013) -
Early pulmonary hypertension is a risk factor for bronchopulmonary dysplasia-associated late pulmonary hypertension in extremely preterm infants
por: Kim, Hyun Ho, et al.
Publicado: (2021) -
Adipose Stem Cell Translational Applications: From Bench-to-Bedside
por: Argentati, Chiara, et al.
Publicado: (2018)